DNA GINKGO BIOWORKS HOLDINGS INC

Ownership history in Jump Financial, LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which Jump Financial, LLC reported a position in GINKGO BIOWORKS HOLDINGS INC (DNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2025 Q2)
Avg. % of fund
0.01%
First filed
2022 Q2
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 17,300 -352,738 -95.3% 0.00% $252K $14.58
2025 Q2 ADDED 370,038 +318,623 +619.7% 0.05% $4.2M $11.25
2024 Q4 REDUCED 51,415 -261,785 -83.6% 0.01% $505K $9.82
2024 Q1 ADDED 313,200 +292,400 +1405.8% 0.01% $363K $46.40
2023 Q4 REDUCED 20,800 -79,200 -79.2% 0.00% $35K $67.60
2023 Q3 ADDED 100,000 +60,244 +151.5% 0.01% $181K $72.40
2023 Q2 REDUCED 39,756 -147,623 -78.8% 0.00% $74K $74.40
2023 Q1 ADDED 187,379 +176,680 +1651.4% 0.01% $249K $53.20
2022 Q3 REDUCED 10,699 -19,601 -64.7% 0.00% $33K $124.80
2022 Q2 INITIATED 30,300 0.00% $72K $95.20
% of Fund (quarterly)    DNA price (monthly, adj. close)
← Back to Jump Financial, LLC Holdings